Czech National Bank Purchases 4,970 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Czech National Bank raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 77,227 shares of the medical equipment provider’s stock after purchasing an additional 4,970 shares during the quarter. Czech National Bank’s holdings in Intuitive Surgical were worth $40,309,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in ISRG. Jupiter Asset Management Ltd. bought a new position in Intuitive Surgical during the 2nd quarter worth $364,000. Wealthspire Advisors LLC raised its position in shares of Intuitive Surgical by 10.9% during the second quarter. Wealthspire Advisors LLC now owns 1,145 shares of the medical equipment provider’s stock worth $509,000 after acquiring an additional 113 shares during the last quarter. Wrapmanager Inc. lifted its stake in shares of Intuitive Surgical by 8.1% in the second quarter. Wrapmanager Inc. now owns 811 shares of the medical equipment provider’s stock worth $361,000 after acquiring an additional 61 shares during the period. Prosperity Consulting Group LLC boosted its holdings in Intuitive Surgical by 24.4% in the second quarter. Prosperity Consulting Group LLC now owns 1,831 shares of the medical equipment provider’s stock valued at $815,000 after acquiring an additional 359 shares during the last quarter. Finally, J.W. Cole Advisors Inc. increased its position in Intuitive Surgical by 37.2% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 2,767 shares of the medical equipment provider’s stock valued at $1,231,000 after purchasing an additional 750 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on ISRG shares. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Piper Sandler restated an “overweight” rating and issued a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Truist Financial lifted their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Stock Up 0.6 %

Intuitive Surgical stock opened at $547.47 on Monday. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $556.23. The company’s 50 day moving average price is $535.93 and its two-hundred day moving average price is $495.17. The stock has a market cap of $195.00 billion, a P/E ratio of 88.02, a P/E/G ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 48,190 shares of company stock valued at $25,012,927. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.